Year One of PHE Regulatory Disruption of Reimbursement: Who Adapted, Who is at Risk, Bad Actors

Stephen Bittinger Partner with K&L Gates in the firm’s Charleston office and a member of the health care/FDA practice group, will lead the presentation Year One of PHE Regulatory Disruption of Reimbursement: Who Adapted, Who is at Risk, Bad Actors at the Healthcare Compliance Symposium 2021 on April 22.

Mr. Bittinger focuses his practice on health care reimbursement compliance, defense and litigation, with a focus on government and private payer disputes on behalf of providers, vendors, and manufacturers involved in the United States health care system. He has extensive experience representing large provider groups, home health agencies, medical facilities, ancillary service providers, medical labs, revenue cycle management companies, and drug and device manufacturers in matters including Medicare and Medicaid audits, private payer audits, federal regulatory termination and exclusion proceedings, False Claims Act prosecutions, and health care revenue issues.

In addition, he has experience advising clients on defending and appealing audits by Recovery Audit Contractors, Zone Program Integrity Contractors, and Unified Program Integrity Contractors and has worked collaboratively with government regulators and health care provider associations across the United States. Bittinger has represented many providers and vendors with federal agency matters in Washington, D.C., including the Centers for Medicare and Medicaid Services (CMS) Center for Program Integrity (CPI), the Department of Health and Human Services Office of Inspector General (HHS-OIG), the Department of Veteran Affairs (VA), and Health Care Fraud division of the Department of Justice (DOJ).

Prior to joining the firm Mr. Bittinger served at a regional commercial law firm where he focused his practice on health care reimbursement defense and litigation. Previously, Mr. Bittinger and team represented numerous types of physician practices, home health agencies, medical facilities, ancillary service providers, medical laboratories, revenue cycle management companies, and drug/device manufacturers in Medicare audits (RAC, ZPIC, UPIC, TPE), Medicaid audits (SIU), private payors audits, federal regulatory termination, and exclusion litigation related to the health care revenue cycle.